Chief Business Officer · Akari Therapeutics Plc · Akari Therapeutics Plc — Stock Option (Right to Buy)
Side
A
Value
—
Shares
87.0K
Price
—
Executed
Oct 12, 2026
Disclosed
Oct 14, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Oct 12 executedOct 14, 2026 disclosed
AKTX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · AKTX
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Akari Therapeutics Plc — Stock Option (Right to Buy)
Ticker
AKTX
Shares
87.0K
Price per share
$0
Execution date (reported)
Oct 12, 2026
Owned after transaction
87.0K shares
Days from execution to publication
2
What this establishes
Vat-Ho Vatnak filed this Form 4 reporting a grant or award of AKTX on Oct 12, 2026. It became public on Oct 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Business Officer
Vat-Ho Vatnakcik:0002160022
Issuer
Akari Therapeutics Plccik:0001541157
Revision history · 0
No field has changed since this record was first ingested.